摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-ethyl (tert-butoxycarbonyl)aminocyclopentene-1-carboxylate | 229613-89-2

中文名称
——
中文别名
——
英文名称
(-)-ethyl (tert-butoxycarbonyl)aminocyclopentene-1-carboxylate
英文别名
ethyl (1S,4R)-4-(tert-butoxycarbonylamino)cyclopent-2-ene-1-carboxylate;(-)-Ethyl cis-4-tert-butoxycarbonylamino-2-cyclopentene-1-carboxylate;(1S,4R)-(-)-Ethyl-4-tert-butoxycarbonylaminocyclopent-2-en-1-carboxylate;ethyl (1S,4R)-4-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopent-2-ene-1-carboxylate
(-)-ethyl (tert-butoxycarbonyl)aminocyclopentene-1-carboxylate化学式
CAS
229613-89-2
化学式
C13H21NO4
mdl
——
分子量
255.314
InChiKey
XAQKSXLQWWIXNN-ZJUUUORDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    18
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    64.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    (-)-ethyl (tert-butoxycarbonyl)aminocyclopentene-1-carboxylateplatinum(IV) oxide 盐酸偶氮二异丁腈氢气三正丁基氢锡异氰酸苯酯三乙胺 作用下, 以 甲醇二氯甲烷甲苯 为溶剂, 20.0~100.0 ℃ 、689.47 kPa 条件下, 反应 82.17h, 生成 (-)-ethyl (1R,3R,4R)-3-[(1S)-1-acetylamino-2-propylpentyl]-4-[(tert-butoxycarbonyl)amino]cyclopentanecarboxylate
    参考文献:
    名称:
    Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo
    摘要:
    Cyclopentane derivatives, designated as BCX-1812, BCX-1827, BCX-1898, and BCX-1923, were tested in parallel with oseltamivir carboxylate and zanamivir for the in vivo activity in mice infected with A/Turkey/Mas/76 X A/Beijing/32/92 (H6N2) influenza virus. The compounds were tested orally and intranasally at different dose levels. BCX-1812, BCX-1827, and BCX-1923 showed more than 50% protection at 1 mg/kg/day dose level on oral treatment. The intranasal treatment was 100% effective even at 0.01 mg/kg/day for all four compounds. On comparison with oseltamivir carboxylate and zanamivir, these four cyclopentane derivatives have shown equal or better efficacies. The synthesis of two new compounds, BCX-1898 and BCX-1923, is also described. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2005.03.048
  • 作为产物:
    描述:
    (1S,4R)-(-)ethyl-4-aminocyclopent-2-ene-1-carboxylate hydrochloride 、 二碳酸二叔丁酯三乙胺 作用下, 以 四氢呋喃 为溶剂, 以81%的产率得到(-)-ethyl (tert-butoxycarbonyl)aminocyclopentene-1-carboxylate
    参考文献:
    名称:
    Synthesis of Highly Functionalized Cyclopentanes as Precursors of Hydroxylated Azidocarbonucleosides
    摘要:
    功能化的叠氮氨基醇的区域异构体和立体异构体以对映体纯净的形式合成。非对映体的2-氮杂双环[2.2.1]庚-5-烯-3-酮经过酶促断环反应生成相应的氨基酸和一个对映体的内酰胺,并具有立体选择性。这些化合物通过酯化和氨基甲酰化被保护,随后进行了环氧化。所得的环氧化合物与叠氮化钠发生了互补的立体选择性裂解。区域异构体产物通过结晶或柱色谱法易于分离。
    DOI:
    10.1055/s-0029-1217088
点击查看最新优质反应信息

文献信息

  • Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
    申请人:BioCryst Pharmaceuticals, Inc.
    公开号:US06762316B1
    公开(公告)日:2004-07-13
    The invention relates to methods for preparing substituted cyclopentene compounds, their intermediates and use as neuraminidase inhibitors.
    本发明涉及制备取代环戊烯化合物的方法,它们的中间体以及作为神经氨酸酶抑制剂的用途。
  • SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS
    申请人:BIOCRYST PHARMACEUTICALS INC.
    公开号:EP1040094B9
    公开(公告)日:2015-09-09
  • US6562861B1
    申请人:——
    公开号:US6562861B1
    公开(公告)日:2003-05-13
  • Synthesis of Highly Functionalized Cyclopentanes as Precursors of Hydroxylated Azidocarbonucleosides
    作者:Ferenc Fülöp、Loránd Kiss、Enikö Forró、Reijo Sillanpää
    DOI:10.1055/s-0029-1217088
    日期:2010.1
    Regio- and stereoisomers of functionalized azido amino alcohols with a cyclopentane skeleton were synthesized in enantiomerically pure forms. Enzymatic ring cleavage of racemic 2-azabicyclo[2.2.1]hept-5-en-3-one gave the corresponding amino acid and one enantiomer of the lactam stereospecifically. These were protected by esterification and carbamoylation, and then epoxidized. The resulting oxiranes underwent cleavage by sodium azide with complementary stereoselectivities. The regioisomeric products were easily separated by crystallization or column chromatography.
    功能化的叠氮氨基醇的区域异构体和立体异构体以对映体纯净的形式合成。非对映体的2-氮杂双环[2.2.1]庚-5-烯-3-酮经过酶促断环反应生成相应的氨基酸和一个对映体的内酰胺,并具有立体选择性。这些化合物通过酯化和氨基甲酰化被保护,随后进行了环氧化。所得的环氧化合物与叠氮化钠发生了互补的立体选择性裂解。区域异构体产物通过结晶或柱色谱法易于分离。
  • Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo
    作者:Pooran Chand、Shanta Bantia、Pravin L. Kotian、Yahya El-Kattan、Tsu-Hsing Lin、Yarlagadda S. Babu
    DOI:10.1016/j.bmc.2005.03.048
    日期:2005.6
    Cyclopentane derivatives, designated as BCX-1812, BCX-1827, BCX-1898, and BCX-1923, were tested in parallel with oseltamivir carboxylate and zanamivir for the in vivo activity in mice infected with A/Turkey/Mas/76 X A/Beijing/32/92 (H6N2) influenza virus. The compounds were tested orally and intranasally at different dose levels. BCX-1812, BCX-1827, and BCX-1923 showed more than 50% protection at 1 mg/kg/day dose level on oral treatment. The intranasal treatment was 100% effective even at 0.01 mg/kg/day for all four compounds. On comparison with oseltamivir carboxylate and zanamivir, these four cyclopentane derivatives have shown equal or better efficacies. The synthesis of two new compounds, BCX-1898 and BCX-1923, is also described. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物